Drug Repurposing for Parkinson’s Disease: The International Linked Clinical Trials experience

Drug Repurposing for Parkinson’s Disease: The International Linked Clinical Trials experience

The international Linked Clinical Trials (iLCT) program for Parkinson’s to date represents one of the most comprehensive drug repurposing programs focused on one disease. Since initial planning in 2010, it has rapidly grown – giving rise to seven completed, and 15 ongoing, clinical trials of 16 agen...

Full description

Bibliographic Details
Main Authors:	Simon R. W. Stott, Richard K. Wyse, Patrik Brundin
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-03-01
Series:	Frontiers in Neuroscience
Subjects:	Parkinson’s neurodegeneration disease modification neuroprotection drug repurposing
Online Access:	https://www.frontiersin.org/articles/10.3389/fnins.2021.653377/full

Similar Items

Neuroprotection by the Immunomodulatory Drug Pomalidomide in the Drosophila LRRK2WD40 Genetic Model of Parkinson’s Disease
by: Maria Antonietta Casu, et al.
Published: (2020-02-01)

The Promise of Neuroprotective Agents in Parkinson’s Disease
by: Judith ePotashkin, et al.
Published: (2011-11-01)

Drug Repurposing for Parkinson’s Disease by Integrating Knowledge Graph Completion Model and Knowledge Fusion of Medical Literature
by: Xiaolin Zhang, et al.
Published: (2021-01-01)

The therapeutic role of minocycline in Parkinson’s disease
by: Seyda Cankaya, et al.
Published: (2019-03-01)

Biological bases for a possible effect of cannabidiol in Parkinson’s disease
by: Nilson C. Ferreira-Junior, et al.

VARIANTS AND PERSPECTIVES OF DRUG REPURPOSING FOR CANCER TREATMENT
by: A. V. Savinkova, et al.
Published: (2018-07-01)

Gauging the role and impact of drug interactions and repurposing in neurodegenerative disorders
by: Dharmendra Kumar Khatri, et al.
Published: (2021-01-01)

Teaching the basics of repurposing mitochondria-targeted drugs: From Parkinson's disease to cancer and back to Parkinson's disease
by: Balaraman Kalyanaraman
Published: (2020-09-01)

Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
by: F. L'Episcopo, et al.
Published: (2011-02-01)

The Emerging Role of Nutrition in Parkinson’s disease
by: Stacey E Seidl, et al.
Published: (2014-03-01)

“Hard” Drug Repurposing for Precision Oncology: The Missing Link?
by: Pan Pantziarka, et al.
Published: (2018-06-01)

Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules
by: Maria João Gouveia, et al.
Published: (2018-02-01)

Drug repurposing: Iron in the fire for older drugs
by: H.V. Sonaye, et al.
Published: (2021-09-01)

Phenotype-Agnostic Molecular Subtyping of Neurodegenerative Disorders: The Cincinnati Cohort Biomarker Program (CCBP)
by: Andrea Sturchio, et al.
Published: (2020-10-01)

Prospects for repurposing CNS drugs for cancer treatment
by: Mohamed Abdelaleem, et al.
Published: (2019-04-01)

Editorial: Drug Repurposing
by: Pan Pantziarka, et al.
Published: (2019-07-01)

Repurposing Pimavanserin, an Anti-Parkinson Drug for Pancreatic Cancer Therapy
by: Sharavan Ramachandran, et al.
Published: (2020-12-01)

Repurposing of existing therapeutics to combat drug-resistant malaria
by: Kanchan Yadav, et al.
Published: (2021-04-01)

Drug repurposing with network reinforcement
by: Yonghyun Nam, et al.
Published: (2019-07-01)

Repurposing Anti-Cancer Drugs for COVID-19 Treatment
by: Borcherding N, et al.
Published: (2020-11-01)

Repurposed agents in the Alzheimer’s disease drug development pipeline
by: Justin Bauzon, et al.
Published: (2020-08-01)

A Review of Repurposed Cancer Drugs in Clinical Trials for Potential Treatment of COVID-19
by: Bárbara Costa, et al.
Published: (2021-05-01)

Mifepristone Repurposing in Treatment of High-Grade Gliomas
by: Monserrat Llaguno-Munive, et al.
Published: (2021-02-01)

Drug combination and repurposing for cancer therapy: the example of breast cancer
by: Ana Salomé Correia, et al.
Published: (2021-01-01)

SAveRUNNER: an R-based tool for drug repurposing
by: Giulia Fiscon, et al.
Published: (2021-03-01)

Systematic integration of biomedical knowledge prioritizes drugs for repurposing
by: Daniel Scott Himmelstein, et al.
Published: (2017-09-01)

Repurposing of the β-Lactam Antibiotic, Ceftriaxone for Neurological Disorders: A Review
by: Ebrahim M. Yimer, et al.
Published: (2019-03-01)

Challenges for Drug Repurposing in the COVID-19 Pandemic Era
by: Janet Sultana, et al.
Published: (2020-11-01)

Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma
by: Rita Rebelo, et al.
Published: (2021-03-01)

Drug Repurposing for the Treatment of Bacterial and Fungal Infections
by: Andrea Miró-Canturri, et al.
Published: (2019-01-01)

Editorial: Drug Repurposing for COVID-19 Therapy
by: Rafael Maldonado, et al.
Published: (2021-08-01)

Repurposing Clinic-Tested Drugs to Treat Rare Neurogenetic Diseases by Transcriptional Modulation
by: Hadwen, Jeremiah
Published: (2018)

Repurposing of Drug Candidates for Treatment of Skin Cancer
by: Hernán Cortés, et al.
Published: (2021-01-01)

Drug Repurposing and DNA Damage in Cancer Treatment: Facts and Misconceptions
by: Eleni Sertedaki, et al.
Published: (2020-05-01)

Proteomics and Drug Repurposing in CLL towards Precision Medicine
by: Dimitra Mavridou, et al.
Published: (2021-07-01)

Drug Repurposing Using Biological Networks
by: Francisco Javier Somolinos, et al.
Published: (2021-06-01)

Repurposing Drugs to Treat Heart and Brain Illness
by: Maranda S. Cantrell, et al.
Published: (2021-06-01)

Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease
by: R.K. Chaturvedi, et al.
Published: (2006-05-01)

Synthetic repurposing of drugs against hypertension: a datamining method based on association rules and a novel discrete algorithm
by: Yosef Masoudi-Sobhanzadeh, et al.
Published: (2020-07-01)

Drug Repurposing Approaches to Combating Viral Infections
by: Jay Trivedi, et al.
Published: (2020-11-01)